Iovance Biotherapeutics, Inc. (LON:0JDK)
London · Delayed Price · Currency is GBP · Price in USD 2.320
0.00 (0.00%)
At close: Sep 17, 2025
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of 587.99 million as of September 17, 2025. Its market cap has decreased by -77.59% in one year.
Market Cap
587.99M
Enterprise Value
406.46M
Revenue
176.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.32
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 587.99M, an increase of 842.48%. That is a compound annual growth rate of 15.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 609.84M | -66.15% |
| Dec 31, 2024 | 1.80B | 10.29% |
| Dec 29, 2023 | 1.63B | 95.13% |
| Dec 30, 2022 | 837.09M | -62.16% |
| Dec 31, 2021 | 2.21B | -55.63% |
| Dec 31, 2020 | 4.99B | 89.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.00B |
| GSK plc | 59.54B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.65B |